Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
CDK1
Cyclin-dependent kinase 1 |
3 |
20 |
Small-scale |
0.822 | High |
|
NHR20
Nuclear hormone receptor family member nhr-20 |
1 |
1 |
High-throughput |
0.541 | High |
|
NHR2
Nuclear hormone receptor family member nhr-2 |
1 |
0 |
High-throughput |
0.518 | High |
|
APC11
Anaphase-promoting complex subunit 11 |
1 |
0 |
High-throughput |
0.518 | High |
|
O16682
RING-type domain-containing protein |
1 |
3 |
High-throughput |
0.494 | High |
|
EF1A
Elongation factor 1-alpha |
1 |
2 |
High-throughput |
0.494 | High |
|
ATTY
Tyrosine aminotransferase |
1 |
1 |
High-throughput |
0.494 | High |
|
F5GU78
Lon proteolytic domain-containing protein |
1 |
0 |
High-throughput |
0.460 | High |
|
O45441
VWFA domain-containing protein |
1 |
1 |
High-throughput |
0.451 | High |
|
O45440
VWFA domain-containing protein |
1 |
1 |
High-throughput |
0.439 | High |
|
Q7Z2A6
MARVEL domain-containing protein |
1 |
1 |
High-throughput |
0.439 | High |
|
H2KZR1
MARVEL domain-containing protein |
1 |
1 |
High-throughput |
0.417 | High |
|
Q18529
Chitin-binding type-2 domain-containing protein |
3 |
0 |
High-throughput |
0.340 | High |
|
EI2BA
Translation initiation factor eIF2B subunit alpha |
2 |
0 |
High-throughput |
0.300 | High |
|
O44669
L-Fucosyltransferase |
1 |
0 |
High-throughput |
0.282 | High |
|
KRAF1
Raf homolog serine/threonine-protein kinase |
1 |
0 |
High-throughput |
0.282 | High |
|
GCDH
Probable glutaryl-CoA dehydrogenase, mitochondrial |
1 |
0 |
High-throughput |
0.282 | High |
|
HRD1
E3 ubiquitin-protein ligase hrd-1 |
1 |
0 |
High-throughput |
0.282 | High |
|
THILH
Acetyl-CoA acetyltransferase homolog, mitochondrial |
1 |
0 |
High-throughput |
0.282 | High |
|
G5EGE1
DH domain-containing protein |
1 |
0 |
High-throughput |
0.251 | Low |
|
Q9TXM1
Uncharacterized protein |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024